These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 18226001

  • 1. Patient characteristics and risk factors for nephrogenic systemic fibrosis following gadolinium exposure.
    Grobner T, Prischl FC.
    Semin Dial; 2008; 21(2):135-9. PubMed ID: 18226001
    [Abstract] [Full Text] [Related]

  • 2. Gadolinium and nephrogenic systemic fibrosis.
    Grobner T, Prischl FC.
    Kidney Int; 2007 Aug; 72(3):260-4. PubMed ID: 17507905
    [Abstract] [Full Text] [Related]

  • 3. Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review.
    Idée JM, Port M, Medina C, Lancelot E, Fayoux E, Ballet S, Corot C.
    Toxicology; 2008 Jun 27; 248(2-3):77-88. PubMed ID: 18440117
    [Abstract] [Full Text] [Related]

  • 4. Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature.
    Lim YL, Lee HY, Low SC, Chan LP, Goh NS, Pang SM.
    Clin Exp Dermatol; 2007 Jul 27; 32(4):353-8. PubMed ID: 17433041
    [Abstract] [Full Text] [Related]

  • 5. [Nephrogenic systemic fibrosis].
    Breitschaft A, Stahlmann R.
    Med Monatsschr Pharm; 2009 Oct 27; 32(10):377-82. PubMed ID: 19886227
    [Abstract] [Full Text] [Related]

  • 6. Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness.
    Canavese C, Mereu MC, Aime S, Lazzarich E, Fenoglio R, Quaglia M, Stratta P.
    J Nephrol; 2008 Oct 27; 21(3):324-36. PubMed ID: 18587720
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis.
    Peak AS, Sheller A.
    Ann Pharmacother; 2007 Sep 27; 41(9):1481-5. PubMed ID: 17684032
    [Abstract] [Full Text] [Related]

  • 8. Nephrogenic systemic fibrosis risk: is there a difference between gadolinium-based contrast agents?
    Penfield JG, Reilly RF.
    Semin Dial; 2008 Sep 27; 21(2):129-34. PubMed ID: 18225999
    [Abstract] [Full Text] [Related]

  • 9. Tissue deposition of gadolinium and development of NSF: a convergence of factors.
    Perazella MA.
    Semin Dial; 2008 Sep 27; 21(2):150-4. PubMed ID: 18226004
    [Abstract] [Full Text] [Related]

  • 10. Current status of gadolinium toxicity in patients with kidney disease.
    Perazella MA.
    Clin J Am Soc Nephrol; 2009 Feb 27; 4(2):461-9. PubMed ID: 19201920
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Nephrogenic systemic fibrosis--new clinical entity].
    Prvulović M.
    Med Pregl; 2008 Feb 27; 61(9-10):439-41. PubMed ID: 19203058
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?
    Boyd AS, Sanyal S, Abraham JL.
    J Am Acad Dermatol; 2010 Feb 27; 62(2):337-42. PubMed ID: 19939504
    [Abstract] [Full Text] [Related]

  • 18. Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis.
    Edward M, Quinn JA, Mukherjee S, Jensen MB, Jardine AG, Mark PB, Burden AD.
    J Pathol; 2008 Apr 27; 214(5):584-93. PubMed ID: 18220317
    [Abstract] [Full Text] [Related]

  • 19. Nephrogenic systemic fibrosis: a sufficient reason to avoid gadolinium-based contrast in all patients with renal impairment?
    Willicombe M, Cunningham J.
    Semin Dial; 2008 Apr 27; 21(2):140-1. PubMed ID: 18226007
    [Abstract] [Full Text] [Related]

  • 20. Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy.
    Kribben A, Witzke O, Hillen U, Barkhausen J, Daul AE, Erbel R.
    J Am Coll Cardiol; 2009 May 05; 53(18):1621-8. PubMed ID: 19406336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.